awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38052066-514D1C8B-5E48-4CF5-A727-05EB286FF044
Q38052066-514D1C8B-5E48-4CF5-A727-05EB286FF044
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38052066-514D1C8B-5E48-4CF5-A727-05EB286FF044
Use of omalizumab in the treatment of food allergy and anaphylaxis.
P2860
Q38052066-514D1C8B-5E48-4CF5-A727-05EB286FF044
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38052066-514D1C8B-5E48-4CF5-A727-05EB286FF044
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2fea3186a9b977f72c1adb4c5e1958f0416a981b
P2860
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy